Pegnano Plus Barivir

Ribavirin · Nanogen Pharmaceutical Biotechnology Joint Stock Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegnano Plus Barivir, covering 2025-06-29 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital [Phase 4]

See pricing